You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Amgen
since
auto-detected in 11 stories
24 days ago
These are the stocks posting the largest moves in extended trading.
44 days ago
Amgen CEO says weight loss drug can address 'patient persistence issue' ⊖
Amgen CEO Bob Bradway discussed his company's weight loss drug in an interview with CNBC's Jim Cramer.
51 days ago
Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more ○
Check out some of the biggest movers in midday trading.
72 days ago
This biotech name is evolving into a major obesity play. How to trade it with options ⊕⊕
Key catalysts, including growing confidence around Amgen’s MariTide obesity program, could transform the name into a growth story.
3 months ago
CEO of drugmaker Amgen talks new results from cholesterol drug trial ⊖
Amgen CEO Bob Bradway told CNBC's Jim Cramer about his company's treatment to reduce heart attack risk.
4 months ago
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers ⊕
Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity.
5 months ago
Amgen to invest $600 million in new research and development facility in California ○
It is the latest U.S. investment by a drugmaker as President Donald Trump threatens to impose tariffs on pharmaceuticals imported into the U.S.
8 months ago
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan ○
found
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
10 months ago
Trump pharma tariffs would raise U.S. drug costs by $51 billion annually, report finds ○
found
Pharmaceutical Research and Manufacturers of America includes Amgen, Bristol Myers Squibb, Eli Lilly, and Pfizer, among others.
11 months ago
Amgen starts two critical late-stage trials for weight loss drug MariTide ○
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli Lilly.